# TDY earnings call intelligence

LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/TDY) · [Earnings tab](https://www.lopjlb.com/stock/TDY?tab=earnings)

Updated: 2026-07-22T07:37:58

Quarters analyzed: 8

## Cross-quarter narrative

Across eight quarterly CallCards Teledyne consistently posted record top‑line and earnings results, with each quarter highlighting higher sales, EPS and free‑cash flow. Early calls emphasized strong defense, aerospace and energy demand while noting weakness in short‑cycle test and measurement markets. By mid‑2025 the company began flagging short‑cycle pull‑forward, tariff cost pressure and integration risk from a spate of bolt‑on acquisitions (Micropac, Qioptiq, later Didi Scientific). The second half of 2025 introduced macro‑level headwinds – a U.S. government shutdown, export‑restriction designations for China and modest FX headwinds – which were reiterated in 2026 alongside new concerns about memory‑component cost inflation and potential regulatory limits on defense‑sector balance‑sheet actions. Despite these risks, defense and digital‑imaging segments delivered accelerating demand, driving margin expansion in 2026. Guidance moved from cautious maintenance to a raised outlook in Q1 2026, reflecting confidence in a robust backlog and low leverage. Capital allocation remained aggressive, with continued share buybacks and a pipeline of strategic acquisitions, while integration of recent deals progressed toward delivery of key programs such as Rogue 1, Black Hornet and space‑based infrared detectors.

## Latest CallCard · Q1

Teledyne reports record Q1 sales, EPS, and operating margin; raises full-year guidance on strong defense/drone demand and book-to-bill 1.16; leverage at 5-year low fuels M&A and CapEx/R&D investment.

**Guidance:** raised — Full-year sales guidance raised to $6.415B (+70bps), non-GAAP EPS midpoint raised to $24 (+$0.35). Q2 non-GAAP EPS guided $5.70-$5.80.

**Tone:** mgmt 0.8 · Q&A pressure 0.4 · divergence 0.3

Prepared remarks highlight record Q1 results, margin expansion, raised full-year guidance, strong backlog, and low leverage, reflecting confidence.

### Demand visibility

Strong demand visibility with record backlog, book-to-bill 1.16 for 10th straight quarter, led by Digital Imaging (1.38) and defense drone/counter-drone orders.

Digital Imaging book-to-bill 1.38 driven by FLIR and DALSA e2v; Instrumentation slightly above 1; A&D and Engineered Systems lumpy but below 1; defense demand elevated for drones, counter-drone, space sensors, maritime surveillance; industrial machine vision and healthcare X-ray inflecting positive.

### Margins / costs

Non-GAAP operating margin expanded 58bps YoY in Q1; full-year expansion ~60bps expected, led by Digital Imaging (+100bps+), with Instrumentation recovering to ~27.5% by Q4.

Digital Imaging margin +107bps to 23.2% despite higher R&D; Instrumentation margin declined due to lower-margin AUV growth and test & measurement weakness; A&D margin +~200bps from acquisitions and leverage; Engineered Systems margin +113bps.

### Capital allocation

Leverage at 5-year low; actively pursuing tuck-in and mid-sized acquisitions; increasing CapEx (~$150M full year) and R&D (+$10M in Q1); targeting >$1B free cash flow.

Q1 FCF $204M vs $225M prior year due to higher inventory; CapEx $29.7M vs $18M; investing in germanium machining capacity and inventory for China supply chain risks; M&A focus on tuck-ins and mid-sized across segments except Engineered Systems.

### Milestones

- **Black Hornet nano drone (Black Hornet 3/4)** [on_track]: Revenue ~$500M over recent years; orders received in US and Europe; Middle East demand increasing
- **Rogue 1 loitering munition** [on_track]: Full-rate production deliveries underway; first contracts received; expected to grow substantially
- **Counter-drone infrared cameras/subsystems** [on_track]: Orders totaling tens of millions in Q1 and early Q2 for counter-drone applications
- **Space-based infrared detectors (SDA tranche programs)** [delivered]: Won nearly all SDA tranche programs; driving double-digit growth in space imaging
- **Golden Dome positioning** [new]: Well positioned for Golden Dome evolution given SDA tranche participation
- **Unmanned subsea vehicles (Gavia, gliders)** [on_track]: Used for mine countermeasures; nice orders in Europe; gliders for long-duration missions
- **Qioptiq acquisition integration** [on_track]: Margin improvement in A&D Electronics segment; cost discipline applied
- **MicroPact acquisition integration** [on_track]: Contributing to A&D Electronics margin improvement

### Fears / risks

- **Foreign exchange headwinds**: FX benefit ~2% in Q1 expected to drop to 0.6% in Q2 and 0% in H2, creating revenue

## Quarter one-liners

- **2026 Q1:** Teledyne reports record Q1 sales, EPS, and operating margin; raises full-year guidance on strong defense/drone demand and book-to-bill 1.16; leverage at 5-year low fuels M&A and CapEx/R&D investment.
- **2025 Q4:** Teledyne reported record Q4 orders, sales and margins, highlighted strong defense and marine demand, announced Didi Scientific acquisition and $400M buyback, and reaffirmed 2026 revenue and earnings guidance.
- **2025 Q3:** Teledyne posted record Q3 sales, earnings and free cash flow, raised its FY sales outlook to $6.06B, noted modest impact from the U.S. shutdown and China designation, and highlighted growth in defense, digital imaging and instrumentation.
- **2025 Q2:** Teledyne posted record Q2 sales and earnings, expects flat Q3 revenue, stays optimistic long‑term but flags short‑cycle pull‑forward and tariff cost risks.
- **2025 Q1:** Teledyne posts record Q1 sales, EPS, margins; closes Qioptiq acquisition; maintains FY25 EPS guidance despite ~1% tariff/GDP hit; leverage 1.8x, strong cash flow, acquisition pipeline healthy.','tone': {'mgmt': 0.6, 'mgmt_rationale': 'Management highlights record results, balanced portfolio resilien
- **2024 Q4:** Teledyne posted record Q4 sales, earnings, margins, and $1.11B free cash flow; guided 2025 sales growth ~4% (3.2% organic) and non-GAAP EPS growth ~8%, cautious on strong USD headwinds; closed Micropac, Excelitas pending.','tone': {'mgmt': 0.2, 'mgmt_rationale': 'Management highlighted record sales,
- **2024 Q3:** Teledyne posts record Q3 sales with sequential growth across segments, raises full-year EPS guidance, sees defense/space strength offsetting weak short-cycle commercial; book-to-bill 1.48, backlog record, M&A pipeline opening.','tone': {'mgmt': 0.3, 'mgmt_rationale': 'Management highlights record sa
- **2024 Q2:** Teledyne Q2: record FCF $301M, margins up in 3 largest segments, book-to-bill 1.07, record backlog; H2 guided sequential growth and YoY return; defense/energy/aerospace strong, industrial/test weak but stabilizing. FCF deployed $852M YTD on debt, buybacks, M&A; leverage 1.7x. Full-year non-GAAP EPS 

## Theme arcs

- **Revenue growth** (improving): Quarterly records from Q2 2024 through Q1 2026 show consistent top‑line acceleration.
- **Margin trajectory** (stable): Margins rose early, faced pressure from integration and tariffs, then expanded again in 2026 as digital‑imaging margins improved.
- **Defense & digital imaging demand** (improving): Strong and growing order flow drove higher book‑to‑bill and backlog, underpinning guidance raises.
- **Short‑cycle commercial volatility** (deteriorating): Repeated mentions of pull‑forward, limited visibility and delayed protocol‑analyzer shipments.
- **Acquisition activity & integration** (new): Series of bolt‑on deals (Micropac, Qioptiq, Didi Scientific) introduced integration risk and temporary margin drag.
- **Macro headwinds (USD, FX, tariffs)** (stable): USD strength noted in Q4 2024, tariff cost exposure in Q2 2025, FX headwinds emerging in Q1 2026.
- **China export restrictions** (resolved): Highlighted in Q2‑Q3 2025, absent from later calls.
- **Capital allocation** (stable): Ongoing share buybacks and aggressive M&A pipeline throughout the period.
- **Guidance outlook** (improving): Moved from maintained to raised full‑year guidance in Q1 2026.

## Fear persistence

- **Short‑cycle demand volatility** [recurring]: Pull‑forward risk and visibility limits noted from Q2 2025 through Q4 2026.
- **Tariff cost exposure** [resolved]: Raised in Q2 2025, not mentioned later.
- **Acquisition integration risk** [recurring]: Highlighted in Q2 2025 and again as margin pressure in Q4 2026.
- **Export restrictions/China designation** [resolved]: Discussed in Q2‑Q3 2025, absent from later calls.
- **Government shutdown risk** [recurring]: First flagged Q3 2025, re‑emerged Q4 2026.
- **Margin pressure** [recurring]: Cited Q3 2025 and Q4 2026 due to cost‑reduction and integration.
- **Seasonality/destocking** [resolved]: Mentioned Q3 2025 only.

## Guidance path

2024 Q2:vague → 2024 Q3:vague → 2024 Q4:vague → 2025 Q1:vague → 2025 Q2:maintained → 2025 Q3:raised → 2025 Q4:maintained → 2026 Q1:raised

---

Research context only. Not personalized investment advice.

API: `GET /bff/api/bigfive/earnings-intel/TDY`
